Clinical trials for Cancer in United States

A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor

Study ID: NCT05275426

Sponsor

Memorial Sloan Kettering Cancer Center

Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease

Study ID: NCT05482126

Sponsor

University of Alabama at Birmingham

A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Study ID: NCT04239157

Sponsor

M.D. Anderson Cancer Center

Resistance Exercise and Creatine in Colorectal Cancer

Study ID: NCT06420726

Sponsor

University of South Carolina

hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)

Study ID: NCT05052957

Sponsor

Leland Metheny

UPLYFT For Lymphoma Survivors

Study ID: NCT05080166

Sponsor

Dana-Farber Cancer Institute

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

Study ID: NCT04099966

Sponsor

Mitchell Cairo

Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).

Study ID: NCT06159166

Sponsor

Johns Hopkins University

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Study ID: NCT06423326

Sponsor

Emory University

Mental Health App for Cancer Survivors Study

Study ID: NCT06472726

Sponsor

University of Wisconsin, Madison